Stock screenerAll disclosures →
EDGAR →
PTN
Conviction 19HealthcareScan · Mon, Aug 10, 2026PTN$7.55-2.83%
ResistanceSupportVol 14Vol MA14 9.78K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price7.55
Change-2.83%
Gap+2.77%
Rel volume1.33×
Avg volume11.6K
Avg $ vol95.76K
SMA 208.14
SMA 5010.51
SMA 20015.31
Price vs 50-28.16%
Price vs 200-50.69%
MA stackbearish
50/200 cross—
Supertrenddown · 10.05
RSI (14)34
MACD hist0.14
MACD crossbull · 9d
Stoch %K / %D25 / 33
ADX (14)47
+DI / −DI7 / 20
RSI divergenceBullish
MACD divergenceBullish
ATR %+10.72%
ADR %9.06%
52w high28.00
52w low0.0941
From 52w high-73.04%
Above 52w low+7923.38%
New 52w highNo
SqueezeOn · 2d
Bollinger width21.68%
%B0.17
Donchian pos13.18%
Donchian high9.79
Donchian low7.21
AVWAP (52w high)16.77
vs AVWAP high-54.97%
AVWAP (52w low)5.16
vs AVWAP low+46.34%
OBV trendDown
Chaikin MF (20)-0.31
Today vs 20d1.33×
Avg vol (14d)9.78K
Avg vol (20d)11.6K
Avg $ vol (20d)95.76K
Market cap—
RS 3m (vs SPY)-64.59%
RS 6m (vs SPY)-65.70%
RS line new highNo
Trend template3/8
Technical rank4.6
1 week-8.26%
1 month-24.50%
3 months-61.22%
6 months-51.97%
1 year+738.89%
YTD-52.96%
P/E-0.81
P/B1.33
P/S—
P/FCF-0.66
EPS-32.15
Div yield—
ROE-163.40%
ROA-130.87%
Debt/Eq0.00
Current5.04
EV/EBITDA-0.23
Gross margin—
Net margin—
Rev growth—
EPS growth41.80%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value3.91M
Revenue3.92M
Net income-1.43M
Gross profit—
Free cash flow-21.31M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out1.78M
Employees29
ListedThu, Nov 4, 1993
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction19 / 100
Pattern quality—
Tech rank4.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.64
Support7.63
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PTN
No recent disclosed trades by Congress in PTN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PTN · 2 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
DUNTON ALAN W Director · StockOption (Right toBuy) · 2026-08-03 | Acquire | 2.2K | — | 2026-08-03 | 2026-08-05 |
Morris Arlene Director · Stock Option (Right to Buy) · 2026-08-03 | Acquire | 2.4K | — | 2026-08-03 | 2026-08-05 |
WILLS STEPHEN T Executive VP and CFO/COO · Common Stock · 2026-07-15 | Tax | 22 | $259 | 2026-07-15 | 2026-07-17 |
WILLS STEPHEN T Executive VP and CFO/COO · Common Stock · 2026-07-15 | Tax | 79 | $926 | 2026-07-15 | 2026-07-17 |
WILLS STEPHEN T Executive VP and CFO/COO · Common Stock · 2026-07-15 | Tax | 94 | $1K | 2026-07-15 | 2026-07-17 |
SPANA CARL President and CEO · Common Stock · 2026-07-15 | Tax | 33 | $388 | 2026-07-15 | 2026-07-17 |
SPANA CARL President and CEO · Common Stock · 2026-07-15 | Tax | 119 | $1K | 2026-07-15 | 2026-07-17 |
SPANA CARL President and CEO · Common Stock · 2026-07-15 | Tax | 142 | $2K | 2026-07-15 | 2026-07-17 |
SEC filings
EDGAR filings in PTN · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.